查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2030 年亚太地区上游生物加工市场预测 - 区域分析 - 按产品类型、工作流程、使用类型和模式
市场调查报告书
商品编码
1567861

2030 年亚太地区上游生物加工市场预测 - 区域分析 - 按产品类型、工作流程、使用类型和模式

Asia Pacific Upstream Bioprocessing Market Forecast to 2030 - Regional analysis - by Product Type, Workflow, Usage Type, and Mode
出版日期: | 出版商: The Insight Partners | 英文 130 Pages | 订单完成后即时交付

价格

2022年亚太上游生物加工市场价值为19.761亿美元，预计2030年将达到56.7899亿美元；预计2022年至2030年复合年增长率为14.1%。

技术进步推动亚太地区上游生物加工市场。

上游生物加工市场正经历一波技术进步浪潮，带来了巨大的产业机会。这些进步包括细胞培养系统、生物反应器设计、製程监测和控制以及自动化和数位化整合的创新发展。 2023 年 9 月，Repligen 公司和 Sartorius 推出了整合生物反应器系统。 Repligen 的 XCell 交替切向流 (ATF) 上游强化技术已整合到 Sartorius Biostat 搅拌釜反应器 (STR) 中。此生物反应器技术旨在使生物製药公司更容易应用氮气灌注和强化种子培养。 Biostat STR 中整合了嵌入式 XCell ATF 硬体和软体模组，该模组将整合製程分析技术与预先定义的高阶控製配方相结合。该模组旨在简化细胞生长的管理并增强灌注过程中的细胞保留，从而无需单独的细胞保留控制塔。此类现代产品具有增强的製程效率、可扩展性和适应性，这对于满足生物製药生产不断变化的需求至关重要。

先进的细胞培养基配方和下一代生物反应器技术有助于上游生物加工的最佳化，进而实现更高的产品产量、改善的产品品质以及复杂生物製剂的高效生产。进阶分析和即时过程监控的持续整合正在彻底改变生物加工中数据驱动的决策，推动精度和製程优化机会。生物技术的进步也促进了灵活和模组化製造平台的发展。此外，机器学习、人工智慧和预测分析的融合正在为预测性生物加工铺平道路，从而释放主动製程控制、品质保证和成本优化的机会。因此，上游生物加工的技术进步正在重塑该产业，为创新、效率和适应性提供了新的途径。

亚太地区上游生物加工市场概况

亚太地区上游生物加工市场分为中国、日本、澳洲、印度、韩国和亚太地区其他地区。预计该地区市场在 2022 年至 2030 年期间将以最高复合年增长率成长。中国、印度和日本是亚太地区市场成长的三个主要贡献者，这主要是由生物反应器需求的成长以及研究中心和政府资助的增加所推动的。此外，许多国际市场参与者将重点放在亚太地区国家，以实现地理扩张和其他策略。

亚太地区上游生物加工市场营收及 2030 年预测（百万美元）

亚太地区上游生物加工市场区隔

亚太地区上游生物加工市场根据产品类型、工作流程、使用类型、模式和国家进行细分。根据产品类型，亚太地区上游生物加工市场分为生物反应器/发酵槽、细胞培养、过滤器、袋子和容器等。 2022 年，生物反应器/发酵槽服务占据最大的市场份额。

根据工作流程，亚太上游生物加工市场分为培养基製备、细胞培养和细胞分离。 2022 年，细胞分离占据最大的市场份额。

根据使用类型，亚太地区上游生物加工市场分为一次性和多用途。到 2022 年，一次性产品将占据更大的市场份额。

根据模式，亚太上游生物加工市场分为内部和外包。 2022 年，In-house 占据了更大的市场份额。

依国家/地区划分，亚太地区上游生物加工市场分为中国、日本、印度、澳洲、韩国和亚太地区其他地区。 2022年，中国将主导亚太地区上游生物加工市场份额。

Thermo Fisher Scientific Inc、Esco Micro Pte Ltd、Sartorius AG、Danaher Corp、Getinge AB、Merck KGaA、Corning Inc 和 Entegris Inc 是亚太上游生物加工市场的一些领先公司。

目录

第 1 章：简介

第 2 章：执行摘要

  • 主要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：亚太地区上游生物加工市场格局

  • 概述
  • PEST分析

第 5 章：亚太地区上游生物加工市场 - 主要市场动态

  • 市场驱动因素
    • 一次性生物反应器的商业用途
    • 生物製药製造外包
    • 医药和生技产业快速成长
  • 市场限制
    • 严格的规范架构
  • 市场机会
    • 技术进步
  • 未来趋势
    • 加大生医产业研发投入
  • 驱动因素和限制的影响：

第 6 章：上游生物加工市场 - 亚太地区分析

第 7 章：亚太地区上游生物加工市场分析 - 按产品类型

  • 生物反应器/发酵罐
  • 细胞培养
  • 过滤器
  • 袋子和容器
  • 其他的

第 8 章：亚太地区上游生物加工市场分析 - 按工作流程

  • 媒体准备
  • 细胞培养
  • 细胞分离

第 9 章：亚太地区上游生物加工市场分析 - 按使用类型

  • 一次使用
  • 多用途

第 10 章：亚太地区上游生物加工市场分析 - 按模式

  • 内部
  • 外包

第 11 章：亚太地区上游生物加工市场 - 国家分析

  • 亚太市场概况
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳洲
      • 韩国
      • 亚太地区其他地区

第 12 章：产业格局

  • 概述
  • 上游生物加工市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 13 章：公司简介

  • Thermo Fisher Scientific Inc
  • Esco Micro Pte Ltd
  • Sartorius AG
  • Danaher Corp
  • Getinge AB
  • Merck KGaA
  • Corning Inc
  • Entegris Inc

第 14 章：附录

Product Code: BMIRE00030685

The Asia Pacific upstream bioprocessing market was valued at US$ 1,976.10 million in 2022 and is expected to reach US$ 5,678.99 million by 2030; it is estimated to grow at a CAGR of 14.1% from 2022 to 2030.

Technological Advancements Boost Asia Pacific Upstream Bioprocessing Market.

The upstream bioprocessing market is experiencing a wave of technological advancements, presenting considerable industry opportunities. These advancements include innovative developments in cell culture systems, bioreactor design, process monitoring, and control, as well as the integration of automation and digitalization. In September 2023, Repligen Corporation and Sartorius introduced an integrated bioreactor system. Repligen's XCell Alternating Tangential Flow (ATF) upstream intensification technology has been integrated into the Sartorius Biostat stirred-tank reactor (STR). This bioreactor technology is designed to make the application of N perfusion and intensified seed train easier for biopharmaceutical firms. An embedded XCell ATF hardware and software module that combines integrated process analytical technologies with predefined advanced control recipes is incorporated into Biostat STR. This module is intended to simplify the management of cell growth and enhance cell retention in perfusion procedures, eliminating the need for a separate cell retention control tower. Such modern products feature enhanced process efficiency, scalability, and adaptability, which are crucial for meeting the evolving demands of biopharmaceutical production.

Advanced cell culture media formulations and next-generation bioreactor technologies are contributing to the optimization of upstream bioprocessing, in turn, enabling higher product yields, improved product quality, and the efficient production of complex biologics. The ongoing integration of advanced analytics and real-time process monitoring is revolutionizing data-driven decision-making in bioprocessing, driving precision and process optimization opportunities. Progress in biotechnology also fosters the development of flexible and modular manufacturing platforms. Additionally, the convergence of machine learning, artificial intelligence, and predictive analytics is paving the way for predictive bioprocessing, thereby unlocking proactive process control, quality assurance, and cost optimization opportunities. Thus, technological advancements in upstream bioprocessing are reshaping the industry, presenting new avenues for innovation, efficiency, and adaptability.

Asia Pacific Upstream Bioprocessing Market Overview

The Asia Pacific upstream bioprocessing market is segmented into China, Japan, Australia, India, South Korea, and the Rest of Asia Pacific. The market in this region is expected to grow at the highest CAGR during 2022-2030. China, India, and Japan are three major contributors to the growth of the market in Asia Pacific, which is mainly driven by rising demand for bioreactors as well as an increase in research centers and government funding. Moreover, many international market players are focusing on countries in Asia Pacific for geographic expansion and other strategies.

Asia Pacific Upstream Bioprocessing Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Upstream Bioprocessing Market Segmentation

The Asia Pacific upstream bioprocessing market is segmented based on product type, workflow, usage type, mode, and country. Based on product type, the Asia Pacific upstream bioprocessing market is segmented into bioreactors/fermenters, cell culture, filters, bags and containers, and others. The bioreactors/fermenters services held the largest market share in 2022.

Based on workflow, the Asia Pacific upstream bioprocessing market is categorized into media preparation, cell culture, and cell separation. The cell separation held the largest market share in 2022.

Based on usage type, the Asia Pacific upstream bioprocessing market is bifurcated into single-use and multi-use. The single-use held a larger market share in 2022.

Based on mode, the Asia Pacific upstream bioprocessing market is bifurcated into In-house and outsourced. The In-house held a larger market share in 2022.

Based on country, the Asia Pacific upstream bioprocessing market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific upstream bioprocessing market share in 2022.

Thermo Fisher Scientific Inc, Esco Micro Pte Ltd, Sartorius AG, Danaher Corp, Getinge AB, Merck KGaA, Corning Inc, and Entegris Inc are some of the leading companies operating in the Asia Pacific upstream bioprocessing market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Upstream Bioprocessing Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Asia Pacific Upstream Bioprocessing Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Commercial Use of Single-Use Bioreactors
    • 5.1.2 Outsourcing of Biopharmaceutical Manufacturing
    • 5.1.3 Rapid Growth of Pharmaceutical and Biotechnology Industries
  • 5.2 Market Restraints
    • 5.2.1 Stringent Regulatory Framework
  • 5.3 Market Opportunities
    • 5.3.1 Technological Advancements
  • 5.4 Future Trends
    • 5.4.1 Increasing Investments in R&D in Biopharmaceutical Industry
  • 5.5 Impact of Drivers and Restraints:

6. Upstream Bioprocessing Market - Asia Pacific Analysis

7. Asia Pacific Upstream Bioprocessing Market Analysis - by Product Type

  • 7.1 Bioreactors/Fermenters
    • 7.1.1 Overview
    • 7.1.2 Bioreactors/Fermenters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.2 Cell Culture
    • 7.2.1 Overview
    • 7.2.2 Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Filters
    • 7.3.1 Overview
    • 7.3.2 Filters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Bags and Containers
    • 7.4.1 Overview
    • 7.4.2 Bags and Containers: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Upstream Bioprocessing Market Analysis - by Workflow

  • 8.1 Media Preparation
    • 8.1.1 Overview
    • 8.1.2 Media Preparation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.2 Cell Culture
    • 8.2.1 Overview
    • 8.2.2 Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Cell Separation
    • 8.3.1 Overview
    • 8.3.2 Cell Separation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Upstream Bioprocessing Market Analysis - by Usage Type

  • 9.1 Single-use
    • 9.1.1 Overview
    • 9.1.2 Single-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.2 Multi-use
    • 9.2.1 Overview
    • 9.2.2 Multi-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Upstream Bioprocessing Market Analysis - by Mode

  • 10.1 In-house
    • 10.1.1 Overview
    • 10.1.2 In-house: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.2 Outsourced
    • 10.2.1 Overview
    • 10.2.2 Outsourced: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)

11. Asia Pacific Upstream Bioprocessing Market - Country Analysis

  • 11.1 Asia Pacific Market Overview
    • 11.1.1 Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country
      • 11.1.1.1 Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country
      • 11.1.1.2 China
      • 11.1.1.3 China: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.3.1 China: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.1.1.3.2 China: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.1.1.3.3 China: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.1.1.3.4 China: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.1.1.4 Japan
      • 11.1.1.5 Japan: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.5.1 Japan: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.1.1.5.2 Japan: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.1.1.5.3 Japan: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.1.1.5.4 Japan: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.1.1.6 India
      • 11.1.1.7 India: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.7.1 India: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.1.1.7.2 India: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.1.1.7.3 India: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.1.1.7.4 India: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.1.1.8 Australia
      • 11.1.1.9 Australia: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.9.1 Australia: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.1.1.9.2 Australia: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.1.1.9.3 Australia: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.1.1.9.4 Australia: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.1.1.10 South Korea
      • 11.1.1.11 South Korea: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.11.1 South Korea: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.1.1.11.2 South Korea: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.1.1.11.3 South Korea: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.1.1.11.4 South Korea: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.1.1.12 Rest of Asia Pacific
      • 11.1.1.13 Rest of Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.13.1 Rest of Asia Pacific: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.1.1.13.2 Rest of Asia Pacific: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.1.1.13.3 Rest of Asia Pacific: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.1.1.13.4 Rest of Asia Pacific: Upstream Bioprocessing Market Breakdown, by Mode

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in Upstream Bioprocessing Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Thermo Fisher Scientific Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Esco Micro Pte Ltd
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Sartorius AG
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Danaher Corp
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Getinge AB
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Merck KGaA
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Corning Inc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Entegris Inc
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. Upstream Bioprocessing Market Segmentation
  • Table 2. Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Product Type
  • Table 3. Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Workflow
  • Table 4. Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Usage Type
  • Table 5. Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Mode
  • Table 6. Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Country
  • Table 7. China: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Product Type
  • Table 8. China: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Workflow
  • Table 9. China: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Usage Type
  • Table 10. China: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Mode
  • Table 11. Japan: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Product Type
  • Table 12. Japan: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Workflow
  • Table 13. Japan: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Usage Type
  • Table 14. Japan: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Mode
  • Table 15. India: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Product Type
  • Table 16. India: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Workflow
  • Table 17. India: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Usage Type
  • Table 18. India: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Mode
  • Table 19. Australia: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Product Type
  • Table 20. Australia: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Workflow
  • Table 21. Australia: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Usage Type
  • Table 22. Australia: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Mode
  • Table 23. South Korea: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Product Type
  • Table 24. South Korea: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Workflow
  • Table 25. South Korea: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Usage Type
  • Table 26. South Korea: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Mode
  • Table 27. Rest of Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Product Type
  • Table 28. Rest of Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Workflow
  • Table 29. Rest of Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Usage Type
  • Table 30. Rest of Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Mode
  • Table 31. Recent Organic Growth Strategies in Upstream Bioprocessing Market
  • Table 32. Recent Inorganic Growth Strategies in the Upstream Bioprocessing Market
  • Table 33. Glossary of Terms, Upstream Bioprocessing Market

List Of Figures

  • Figure 1. Upstream Bioprocessing Market Segmentation, by Country
  • Figure 2. PEST Analysis
  • Figure 3. Upstream Bioprocessing Market - Key Market Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Upstream Bioprocessing Market Revenue (US$ Million), 2020-2030
  • Figure 6. Upstream Bioprocessing Market Share (%) - by Product Type (2022 and 2030)
  • Figure 7. Bioreactors/Fermenters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Filters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Bags and Containers: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Others: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Upstream Bioprocessing Market Share (%) - by Workflow (2022 and 2030)
  • Figure 13. Media Preparation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Cell Separation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Upstream Bioprocessing Market Share (%) - by Usage Type (2022 and 2030)
  • Figure 17. Single-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Multi-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Upstream Bioprocessing Market Share (%) - by Mode (2022 and 2030)
  • Figure 20. In-house: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Outsourced: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Asia Pacific: Upstream Bioprocessing Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 23. Asia Pacific: Upstream Bioprocessing Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 24. China: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Japan: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. India: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Australia: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. South Korea: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Rest of Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 30. Growth Strategies in Upstream Bioprocessing Market